AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimilife-M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Lakshya Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimilife-M1 Tablet PR

DiaBeta-Duo tablets are antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. They help regulate blood glucose levels. DiaBeta-Duo should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a healthy diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and trembling. Regular meals and readily available glucose sources (sugary foods or juice) are essential preventative measures. Alcohol consumption should be avoided due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Glimilife-M1 Tablet PR

No text provided to rephrase.

Uses of Glimilife-M1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimilife-M1 Tablet PR:

Follow your doctor's instructions or consult the product information leaflet for usage guidance. Take Glimilife-M1 Tablet PR with food.

Common Side effects of Glimilife-M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimilife-M1 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidelines. Take Glimilife-M1 Tablet PR with meals.

How Glimilife-M1 Tablet PR works:

Glimilife-M1 PR tablets contain a dual-action antidiabetic formula: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimilife-M1 Tablet PR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimilife-M1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Use of Glimilife-M1 Tablet PR while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimilife-M1 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician before taking this medication. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimilife-M1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, Glimilife-M1 Tablet PR initiation should be at a low dosage; it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimilife-M1 Tablet PR :

Should you forget a dose of Glimilife-M1 Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimilife-M1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Glimilife-M1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimilife-M1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimilife-M1 Tablet PR and seek immediate medical attention.
Glimilife-M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. It enhances blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glimilife-M1 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimilife-M1 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate these risks, supplemental vitamin B12 is recommended at least annually.
Glimilife-M1 Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimilife-M1 Tablet PR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimilife-M1 Tablet PR
53
MRP 65
18% off